Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C M Teng

Showing results (281-290 of 287) with videos related to

Pageof 29
Sort By:
You have reached the last page of results.This site can display upto 287 results.
Cell Death & Disease|April 12, 2014
Orally active microtubule-targeting agent, MPT0B271, for the treatment of human non-small cell lung cancer, alone and in combination with erlotinibA-C Tsai, C-Y Wang, J-P Liou, et al.
Journal of Natural Products|September 1, 1996
Novel antiplatelet constituents from formosan moraceous plantsC N Lin, C M Lu, H C Lin, et al.
The Journal of Pharmacy and Pharmacology|September 1, 1996
Synthesis and antithrombotic effect of xanthone derivativesC N Lin, H K Hsieh, S J Liou, et al.
Oncogene|January 11, 2007
YC-1 inhibits HIF-1 expression in prostate cancer cells: contribution of Akt/NF-kappaB signaling to HIF-1alpha accumulation during hypoxiaH-L Sun, Y-N Liu, Y-T Huang, et al.
The Journal of Pharmacy and Pharmacology|January 24, 2002
Synthesis, antiplatelet and vasorelaxing effects of monooxygenated flavones and flavonoxypropanolaminesM I Chung, F W Han, H C Lin, et al.
Planta Medica|June 1, 1991
6-Pentadecylsalicylic acid: an antithrombin component isolated from the stem of Rhus semialata var. roxburghiiS C Kuo, C M Teng, L G Lee, et al.
British Journal of Pharmacology|July 22, 2008
YC-1 induces apoptosis of human renal carcinoma A498 cells in vitro and in vivo through activation of the JNK pathwayS Y Wu, S L Pan, T H Chen, et al.
Pageof 29

Showing results (281-290 of 287) with videos related to

Sort By:
Pageof 29
You have reached the last page of results.This site can display upto 287 results.
Cell Death & Disease|April 12, 2014
Orally active microtubule-targeting agent, MPT0B271, for the treatment of human non-small cell lung cancer, alone and in combination with erlotinibA-C Tsai, C-Y Wang, J-P Liou, et al.
Journal of Natural Products|September 1, 1996
Novel antiplatelet constituents from formosan moraceous plantsC N Lin, C M Lu, H C Lin, et al.
The Journal of Pharmacy and Pharmacology|September 1, 1996
Synthesis and antithrombotic effect of xanthone derivativesC N Lin, H K Hsieh, S J Liou, et al.
Oncogene|January 11, 2007
YC-1 inhibits HIF-1 expression in prostate cancer cells: contribution of Akt/NF-kappaB signaling to HIF-1alpha accumulation during hypoxiaH-L Sun, Y-N Liu, Y-T Huang, et al.
The Journal of Pharmacy and Pharmacology|January 24, 2002
Synthesis, antiplatelet and vasorelaxing effects of monooxygenated flavones and flavonoxypropanolaminesM I Chung, F W Han, H C Lin, et al.
Planta Medica|June 1, 1991
6-Pentadecylsalicylic acid: an antithrombin component isolated from the stem of Rhus semialata var. roxburghiiS C Kuo, C M Teng, L G Lee, et al.
British Journal of Pharmacology|July 22, 2008
YC-1 induces apoptosis of human renal carcinoma A498 cells in vitro and in vivo through activation of the JNK pathwayS Y Wu, S L Pan, T H Chen, et al.
Pageof 29